RASKE FORSØGSPERSONER in English translation

• healthy subjects
• healthy volunteers

Examples of using Raske forsøgspersoner in Danish and their translations into English

I en række kliniske forsøg blev 541 cancerpatienter og 188 raske forsøgspersoner eksponeret for Biograstim.
During clinical studies 541 cancer patients and 188 healthy volunteers were exposed to Biograstim.

Absolut biotilgængelighed af en 500 mg eller 850 mg metformin tablet er cirka 50- 60% hos raske forsøgspersoner.
Absolute bioavailability of a 500 mg or 850 mg metformin tablet is approximately 50-60% in healthy subjects.

Små, klinisk ubetydelige, reversible forhøjelser i serumkreatininniveauet er observeret hos raske forsøgspersoner og patienter, der er behandlet med Ranexa.
Small, clinically insignificant, reversible elevations in serum creatinine levels have been observed in healthy subjects and patients treated with Ranexa.

Generelt var emtricitabins farmakokinetik hos HBV- inficerede patienter den samme som hos raske forsøgspersoner og hos HIV- inficerede patienter.
In general, emtricitabine pharmacokinetics in HBV infected patients were similar to those in healthy subjects and in HIV infected patients.

flerdosis telbivudin blev vurderet på raske forsøgspersoner og patienter med kronisk hepatitis B.
multiple-dose pharmacokinetics of telbivudine were evaluated in healthy subjects and in patients with chronic hepatitis B.

blev halveringstiden for venlafaxin og ODV forlænget i forhold til raske forsøgspersoner.
ODV half-lives were prolonged compared to normal subjects.

en række ældre studier, hvor den koncentration, som ikke har givet allergi hos raske forsøgspersoner var 0,8% cinnamyl alcohol(no-effect level) 55,57.
where the concentration which did not produced allergy in healthy persons was 4% cinnamyl alcohol(no-effect level) 55, 57.

Farmakokinetikken af IntronA blev undersøgt hos raske forsøgspersoner efter enkeltdoser på 5 millioner IE/ m2
The pharmacokinetics of IntronA were studied in healthy volunteers following single 5 million IU/m2

En undersøgelse, der blev udført med 7 normale raske forsøgspersoner, viste at cimetidin,
A study conducted in seven normal healthy volunteers showed that cimetidine,

er det ikke muligt at afgøre, hvorvidt der er forskelle sammenlignet med raske forsøgspersoner.
it is not possible to determine whether there are any differences compared with healthy volunteers.

non- neutropene patienter med candidæmi eller aspergillosis og raske forsøgspersoner.
non-neutropenic patients with candidaemia or aspergillosis and healthy volunteers.

den terminale halveringstid svarede til den, som blev målt på raske forsøgspersoner.
the terminal half-life was similar to that measured in healthy volunteers.

Hos hæmodialysepatienter var Cmax 41% højere end hos raske forsøgspersoner.
In haemodialysis patients, Cmax was 41% higher than that observed in healthy subjects.

Der er ikke udført specifikke farmakodynamiske interaktionsstudier på ældre raske forsøgspersoner.
No specific pharmacodynamic interaction studies were conducted in elderly volunteers.

kløe og hypotension hos raske forsøgspersoner.
itching or hypotension in healthy subjects.

Køn Kønnets betydning for doripenems farmakokinetik blev evalueret hos raske forsøgspersoner af begge køn.
Gender The effect of gender on the pharmacokinetics of doripenem was evaluated in healthy male and female subjects.

Halveringtiden af reteplase var forøget hos patienter med AMI sammenlignet med raske forsøgspersoner.
The half-life of reteplase was increased in patients with AMI as compared to healthy volunteers.

Den totale kropsclearance hos disse patienter er dog den samme som hos raske forsøgspersoner.
Severe renal impairment reduces renal clearance, however total body clearance in these patients is similar to healthy subjects.

Der sås ikke tegn på øget eksponering hos dem med nedsat leverfunktion sammenlignet med raske forsøgspersoner.
No signs of increased exposure in the hepatically impaired subjects were observed compared to healthy subjects.

Generelle farmakokinetiske karakteristika Anidulafungins farmakokinetik er beskrevet hos raske forsøgspersoner, i specielle populationer og hos patienter.
General pharmacokinetic characteristics The pharmacokinetics of anidulafungin have been characterised in healthy subjects, special populations and patients.